Laurence Knutson

Part of Otsuka Holdings Co., Ltd., Sparta Pharmaceuticals, Inc. acquires the rights to, and develops for commercialization, technologies and drugs for the treatment of diseases. The company is based in Horsham, PA. Sparta Pharmaceuticals was acquired by SuperGen, Inc. on August 13, 1999 for $12.28 million. The company was founded by Peter N. Christos.

SCP Private Equity Partners (SCP Partners) is a private equity firm founded in 1996 by Winston J. Churchill. The firm is headquartered in Malvern, Pennsylvania.

Biophage Pharma, Inc. is a biotechnology company. It develops phage-based products and technologies for the detection, prevention and control of bacterial infections. It operates through two divisions: Therapeutic and Biosensors. The Therapeutic division is engaged in the management of bacterial contaminations in the medical, veterinary and environmental. The Biosensors division is to the development and commercialization of novel biosensors. Biophage Pharma was founded in 1995 and is headquartered in Montreal, Canada.

Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.

Regulatory Affairs Professionals Society is a non-profit organization that offers healthcare products. The non-profit company is based in Rockville, MD.

Kuehnle AgroSystems, Inc. develops algae strains for use in bio fuel and chemical production. It develops and produce algae based solutions for skin and personal care, specialty chemicals, wastewater treatment with CO2 capture and aquaculture & animal nutrition. The company was founded by Paul S. Zorner, Adelheid R. Kuehnle and Gordon O. Wallace in 1998 and is headquartered in Honolulu, H

Leversense LLC develops next generation diagnostic biosensor technology. It intends to develop a medical device for detecting AIDS, food toxin, and mycoplasma bacteria. The company was founded by Pete A. Nagy in 2006 and is headquartered in Newtown Square, PA.

Part of Takeda Pharmaceutical Co., Ltd., CytoMed, Inc. is a company that develops therapeutics for cancer treatment. The company is based in Cambridge, MA. CytoMed was acquired by LeukoSite, Inc., part of Takeda Pharmaceutical Co., Ltd. from December 22, 1999 on February 12, 1999 for $19.29 million.

Part of Omnicom Group, Inc., QED Technologies LP provides life science consulting services. The company is based in Malvern, PA. QED Technologies was acquired by Omnicom Group, Inc. on November 10, 1999. The company was founded by Dick L. Sherman.

Part of GSK Plc, Smithkline Beckman Corp is a company that manufactures pharmaceutical products. The company is based in Philadelphia, PA. Smithkline Beckman was acquired by Smithkline Beecham Plc on July 27, 1989 for $16,082.37 million.

University of Hawai'i at Hilo engages in the provision of services relating to higher education. It offers bachelor’s degrees, minors, master’s degrees, doctoral degrees, certificate programs, graduate certificate programs, and distance learning. The company was founded in 1947 and is headquartered in Hilo, HI.

Invencor, Inc. is an Independent Venture Capital firm founded in 1997 by Kirk B. Westbrook. The firm is headquartered in California.

BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA.

Part of DNAPrint Genomics, Inc., Kenna Technologies, Inc. is a technology company. The company is based in West Chester, PA. Kenna Technologies was acquired by DNAPrint Genomics, Inc. on November 01, 2005 for $0.02 million. The company's description is "Latest Tech Info".

Life Sciences Pennsylvania (LSPA) is a trade association that represents various entities in the life sciences industry, including biotechnology, medical device, diagnostic, pharmaceutical, research, and investment companies, as well as service providers. The non-profit company is based in Wayne, PA and has subsidiaries in the United States. The organization unifies innovators in the state to make Pennsylvania a leader in the life sciences industry. Founded in 1989, LSPA aims to create a business and public policy environment that encourages and incentivizes the diverse life sciences economy in Pennsylvania. Christopher P. Molineaux has been the CEO of the company since 2009.

The Drug Information Association is a non-profit multidisciplinary association that operates to promote health and well-being. The non-profit company is based in Horsham, PA. Marwan Fathallah has been the CEO of the company since 2023.

SCP Vitalife Partners (SCP Vitalife) is a venture capital firm founded in 2000 by Dr. Abraham Ludomirski and Wayne B. Weisman. The firm is headquartered in Malvern, Philadelphia with additional office in Israel.

Malvern Consulting Group, Inc. is engaged in pre-clinical, clinical, regulatory, quality, manufacturing, and packaging services. It also offers Medical Writing, Strategic Consulting and development services. The company was founded by Geraldine A. Henwood and is headquartered in Malvern, PA.

Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA.

DTRIC Insurance Co. Ltd. (Investment Portfolio) (DTRIC-IP) is the investment portfolio division of DTRIC Insurance Co. Ltd, an insurance company headquartered in Honolulu, Hawaii. The firm is a subsidiary of Aioi Nissay Dowa Insurance Co. Ltd., which is owned by MS&AD Insurance Group Holdings, Inc. (TYO: 8725). DTRIC-IP manages the investment portfolio of insurance clients.

Cnd Life Sciences, Inc. is a company based in an undisclosed location that aims to transform the diagnosis and treatment of neurodegenerative diseases. The company is based in Scottsdale, AZ. The company operates a CLIA-certified and CAP-accredited laboratory and has launched the Syn-One test, the world's first commercially available test that detects and visualizes phosphorylated alpha-synuclein in cutaneous nerves with high accuracy to aid the diagnosis of Parkinson's disease and related disorders. Cnd Life Sciences has scientific collaborations with biopharmaceutical companies and has been awarded three NIH SBIR grants to advance the clinical utility of the Syn-One test. The company allows clinicians to access objective pathological insights on diseases that are often difficult to diagnose and apply those insights to generate better outcomes for patients. The company was founded in 2017 by Todd Dylan Levine, Christopher Gibbons, Roy Freeman, and the CEO is Richard J. Morello.